Literature DB >> 14643611

Studies on bone marrow stromal cells affinity of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate).

Ming Yang1, Shanshan Zhu, Yue Chen, Zhijie Chang, Guoqiang Chen, Yandao Gong, Nanming Zhao, Xiufang Zhang.   

Abstract

The objective of this study is to investigate the biocompatibility of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) with bone marrow stromal cells in vitro. The adsorption of fibronectin on the material was studied by enzyme-linked immunosorbent assay. After bone marrow stromal cells were seeded and cultured on PHBHHx, their proliferation was investigated by MTT. Differentiation of the cells was assessed by measuring alkaline phosphatase activity and by histochemical assay. The wettability and thermal property of PHBHHx films were also studied by contact angle goniometer, thermogravimetry and differential scanning calorimetry, respectively. The results show that bone marrow stromal cells can attach, proliferate and differentiate into osteoblasts on PHBHHx films. These results suggest that PHBHHx has good affinity with bone marrow stromal cells and may have potential applications in bone tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14643611     DOI: 10.1016/j.biomaterials.2003.08.018

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

1.  Research of osteoblastic induced rat bone marrow mesenchymal stem cells cultured on β-TCP/PLLA porous scaffold.

Authors:  Yi Yang; Jiang Wu; Gele Jin; Liang Li; Zhongwei Li; Cao Li
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Effect of starch-based biomaterials on the in vitro proliferation and viability of osteoblast-like cells.

Authors:  A P Marques; H R Cruz; O P Coutinho; R L Reis
Journal:  J Mater Sci Mater Med       Date:  2005-09       Impact factor: 3.896

3.  In vitro biocompatibility assessment of PHBV/Wollastonite composites.

Authors:  Haiyan Li; Wanying Zhai; Jiang Chang
Journal:  J Mater Sci Mater Med       Date:  2007-06-19       Impact factor: 3.896

4.  Comparison of physical, chemical and cellular responses to nano- and micro-sized calcium silicate/poly(epsilon-caprolactone) bioactive composites.

Authors:  Jie Wei; S J Heo; D H Kim; S E Kim; Y T Hyun; Jung-Woog Shin
Journal:  J R Soc Interface       Date:  2008-06-06       Impact factor: 4.118

5.  The implantable and biodegradable PHBHHx 3D scaffolds loaded with protein-phospholipid complex for sustained delivery of proteins.

Authors:  Qiang Peng; Yong-Jie Yang; Ting Zhang; Cheng-Yu Wu; Qin Yang; Xun Sun; Tao Gong; Ling Zhang; Zhi-Rong Zhang
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

6.  Additive Manufacturing of Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)/poly(ε-caprolactone) Blend Scaffolds for Tissue Engineering.

Authors:  Dario Puppi; Andrea Morelli; Federica Chiellini
Journal:  Bioengineering (Basel)       Date:  2017-05-24

7.  Chondrocyte Co-cultures with the Stromal Vascular Fraction of Adipose Tissue in Polyhydroxybutyrate/Poly-(hydroxybutyrate-co-hydroxyhexanoate) Scaffolds: Evaluation of Cartilage Repair in Rabbit.

Authors:  Kai Ba; Xueqin Wei; Duan Ni; Na Li; Tianfeng Du; Xinbo Wang; Wenting Pan
Journal:  Cell Transplant       Date:  2019-07-24       Impact factor: 4.064

Review 8.  Development and Advantages of Biodegradable PHA Polymers Based on Electrospun PHBV Fibers for Tissue Engineering and Other Biomedical Applications.

Authors:  Łukasz Kaniuk; Urszula Stachewicz
Journal:  ACS Biomater Sci Eng       Date:  2021-10-14

9.  Study on antibacterial properties and cytocompatibility of EPL coated 3D printed PCL/HA composite scaffolds.

Authors:  Lijiao Tian; Zhenting Zhang; Bin Tian; Xin Zhang; Na Wang
Journal:  RSC Adv       Date:  2020-01-29       Impact factor: 4.036

10.  Progress and challenges in biomaterials used for bone tissue engineering: bioactive glasses and elastomeric composites.

Authors:  Qizhi Chen; Chenghao Zhu; George A Thouas
Journal:  Prog Biomater       Date:  2012-09-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.